Page last updated: 2024-08-24

adapalene and Colorectal Cancer

adapalene has been researched along with Colorectal Cancer in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chayahara, N; Doi, H; Fujishima, Y; Fukunaga, A; Kawaguchi, A; Kiyota, N; Kobayashi, K; Marugami, N; Minami, H; Mizuta, N; Mukohara, T; Nakata, K; Nishigori, C; Nishimura, Y; Tachihara, M; Takenaka, K; Tobimatsu, K; Toyoda, M; Washio, K; Yamamoto, M	1
Kung, HF; Leung, KS; Li, H; Li, L; Lin, MC; Liu, X; Shi, XN; Yao, H	1
Ganslmayer, M; Hahn, EG; Herold, C; Ocker, M; Schuppan, D	1

Trials

1 trial(s) available for adapalene and Colorectal Cancer

Article	Year
Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE). The oncologist, 2019, Volume: 24, Issue:7 Topics: Acne Vulgaris; Adapalene; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dermatologic Agents; ErbB Receptors; Exanthema; Female; Follow-Up Studies; Gels; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors	2019

Article

Year

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).

The oncologist, 2019, Volume: 24, Issue:7

Topics: Acne Vulgaris; Adapalene; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dermatologic Agents; ErbB Receptors; Exanthema; Female; Follow-Up Studies; Gels; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors

2019

Other Studies

2 other study(ies) available for adapalene and Colorectal Cancer

Article	Year
Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma. Molecular medicine reports, 2015, Volume: 12, Issue:5 Topics: Adapalene; Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclin E; Cyclin-Dependent Kinase 2; Drug Combinations; Female; Gene Expression; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Organoplatinum Compounds; Oxaliplatin; Phosphorylation; Retinoblastoma Protein; Tumor Burden; Xenograft Model Antitumor Assays	2015
The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. International journal of cancer, 2003, Nov-10, Volume: 107, Issue:3 Topics: Adapalene; Alitretinoin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Division; Colorectal Neoplasms; Humans; Naphthalenes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tretinoin; Tumor Cells, Cultured	2003

Article

Year

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma.

Molecular medicine reports, 2015, Volume: 12, Issue:5

Topics: Adapalene; Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclin E; Cyclin-Dependent Kinase 2; Drug Combinations; Female; Gene Expression; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Organoplatinum Compounds; Oxaliplatin; Phosphorylation; Retinoblastoma Protein; Tumor Burden; Xenograft Model Antitumor Assays

2015

The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro.

International journal of cancer, 2003, Nov-10, Volume: 107, Issue:3

Topics: Adapalene; Alitretinoin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Division; Colorectal Neoplasms; Humans; Naphthalenes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tretinoin; Tumor Cells, Cultured

2003